Bausch Health Companies (BHC) EBT (2009 - 2026)
Bausch Health Companies (BHC) posted EBT of $348.0 million for Q2 2026, up 125.7% sequentially from -$1.4 billion in Q1 2026, and up 148.57% YoY from $140.0 million in Q2 2025.
Bausch Health Companies (BHC) EBT (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported EBT for 18 years, with the latest figure at $348.0 million in Q2 2026.
- Quarterly EBT rose 148.57% year-over-year to $348.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$732.0 million (down 360.5% YoY) and the FY2025 annual result came in at $367.0 million, up 119.76% from the prior year.
- EBT improved to $348.0 million in Q2 2026 per BHC's latest filing, from -$1.4 billion in the prior quarter.
- Over five years, EBT peaked at $439.0 million in Q3 2022 and troughed at -$1.4 billion in Q1 2026.
- A 5-year average of -$55.1 million and a median of -$14.0 million in 2023 frame the typical range for EBT.
- The sharpest annual moves came in 2024 and 2026: EBT soared 3085.71% in 2024, then tumbled 2780.85% in 2026.
- Over 5 years, EBT stood at -$357.0 million in 2022, then surged by 98.04% to -$7.0 million in 2023, then jumped by 3085.71% to $209.0 million in 2024, then sank by 73.21% to $56.0 million in 2025, then soared by 521.43% to $348.0 million in 2026.
- According to Business Quant data, EBT over the past three periods registered $348.0 million, -$1.4 billion, and $56.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Bausch Health Companies | 2.58 Bn | 740.13 Mn | 2.10 Bn | 348.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 348.00 Mn |
| Mar 31, 2026 | -1.35 Bn |
| Dec 31, 2025 | 56.00 Mn |
| Sep 30, 2025 | 218.00 Mn |
| Jun 30, 2025 | 140.00 Mn |
| Mar 31, 2025 | -47.00 Mn |
| Dec 31, 2024 | 209.00 Mn |
| Sep 30, 2024 | -21.00 Mn |
| Jun 30, 2024 | 48.00 Mn |
| Mar 31, 2024 | -69.00 Mn |
| Dec 31, 2023 | -7.00 Mn |
| Sep 30, 2023 | -326.00 Mn |
| Jun 30, 2023 | 79.00 Mn |
| Mar 31, 2023 | -136.00 Mn |
| Dec 31, 2022 | -357.00 Mn |
| Sep 30, 2022 | 439.00 Mn |
| Jun 30, 2022 | -129.00 Mn |
| Mar 31, 2022 | -82.00 Mn |
| Dec 31, 2021 | 21.00 Mn |
| Sep 30, 2021 | 216.00 Mn |